These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1786702)

  • 21. Effects of CCK receptor blockade on intestinal motor activity in conscious dogs.
    Niederau C; Karaus M
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G315-24. PubMed ID: 1996649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
    Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCK-octapeptide injected into cerebral ventricles of sheep decreases plasma insulin level.
    Della-Fera MA; Baile CA
    Physiol Behav; 1985 Feb; 34(2):283-9. PubMed ID: 3889948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone (GH)-releasing factor stimulates hypothalamic somatostatin release: an inhibitory feedback effect on GH secretion.
    Katakami H; Arimura A; Frohman LA
    Endocrinology; 1986 May; 118(5):1872-7. PubMed ID: 3084210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.
    Lieverse RJ; Jansen JB; Masclee AA; Rovati LC; Lamers CB
    Gut; 1994 Apr; 35(4):501-5. PubMed ID: 8174988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of leptin in the control of feeding of goldfish Carassius auratus: interactions with cholecystokinin, neuropeptide Y and orexin A, and modulation by fasting.
    Volkoff H; Eykelbosh AJ; Peter RE
    Brain Res; 2003 May; 972(1-2):90-109. PubMed ID: 12711082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with cholecystokinin receptor antagonist loxiglumide enhances insulin response to intravenous glucose stimulation in postpancreatitic rats.
    Otsuki M; Nakano S; Tachibana I
    Regul Pept; 1994 Jul; 52(2):85-95. PubMed ID: 7972939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of the cholecystokinin antagonist, proglumide, on prolactin secretion in the rat.
    Vijayan E; McCann SM
    Life Sci; 1987 Feb; 40(7):629-34. PubMed ID: 3807652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loxiglumide, L-364,718 and L-365,260 prevent the inhibition of spontaneous acetylcholine release from the frontal cerebral cortex of freely moving rat peripherally administered with cholecystokinin-8S.
    Kimura I; Wakasono S; Kimura M
    Jpn J Pharmacol; 1995 May; 68(1):129-32. PubMed ID: 7494376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracerebroventricular and intravenous administration of growth hormone secretagogue L-692,585, somatostatin, neuropeptide Y and galanin in pig: dose-dependent effects on growth hormone secretion.
    Cho SJ; Lee JS; Mathias ED; Chang C; Hickey GJ; Lkhagvadorj S; Anderson LL
    Comp Biochem Physiol C Toxicol Pharmacol; 2010 May; 151(4):412-9. PubMed ID: 20074661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of cholecystokinin and the cholinergic system in intravenous amino acid-induced gallbladder emptying.
    Gielkens HA; de Boer SY; Lam WF; Rovati LC; Lamers CB; Masclee AA
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1227-31. PubMed ID: 9471030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of endogenous cholecystokinin and somatostatin in gastroprotection induced by intraduodenal fat.
    Brzozowski T; Konturek PC; Konturek SJ; Kwiecién S; Pajdo R; Brzozowska I; Hahn EG
    J Clin Gastroenterol; 1998; 27 Suppl 1():S125-37. PubMed ID: 9872509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of effect of the specific cholecystokinin receptor antagonist loxiglumide on cholecystokinin clearance from plasma in man.
    Jebbink MC; Jansen JB; Masclee AA; Lamers CB
    Br J Clin Pharmacol; 1990 Jun; 29(6):770-3. PubMed ID: 2378793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of somatostatin and loxiglumide on gallbladder motility.
    Lieverse RJ; Jansen JB; Jebbink MC; Masclee AA; Rovati LC; Lamers CB
    Eur J Clin Pharmacol; 1995; 47(6):489-92. PubMed ID: 7768249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effects of PGE2, 2-DG and L-arginine on hypothalamic GHRH and SRIF releases in conscious rats, with respect to GH secretion].
    Kimura S; Kameyama K; Hosoi E; Saito S
    Nihon Naibunpi Gakkai Zasshi; 1989 Feb; 65(2):113-27. PubMed ID: 2568278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCK administration after CCK receptor blockade accelerates recovery from cerulein-induced acute pancreatitis in rats.
    Nakano S; Kihara Y; Otsuki M
    Pancreas; 1998 Mar; 16(2):169-75. PubMed ID: 9510141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholecystokinin in the control of gastric acid secretion and gastrin release in response to a meal at low and high pH in healthy subjects and duodenal ulcer patients.
    Konturek JW; Konturek SJ; Domschke W
    Scand J Gastroenterol; 1995 Aug; 30(8):738-44. PubMed ID: 7481540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of cholecystokinin antagonists on satiety induced by cholecystokinin octapeptide in dogs].
    Sakatani N; Inui A; Baba S
    Nihon Naibunpi Gakkai Zasshi; 1989 Oct; 65(10):1149-58. PubMed ID: 2591604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.